SEC Form 4 · accession 0001140361-16-067873
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M Anne Szostak
Director
Period of report
May 27, 2016
Accepted (ET)
May 31, 2016 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 27, 2016 | G | 6,600 | $0.00 | D | 0 | I | 2014 Szostak IDEXX GRAT |
| Common StockF1 | May 27, 2016 | G | 6,600 | $0.00 | A | 15,416 | I | M. Anne Szostak Trust |
| Common Stock | holding | — | — | — | 584 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares have been transferred from the 2014 Szostak IDEXX GRAT to the M. Anne Szostak Trust (the "Trust"). The reporting person is the settlor of the Trust, the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares transferred to the Trust.